Molbio Diagnostics raised ₹281.5 crore from anchor investors ahead of its ₹940-crore IPO, with participation from Goldman Sachs, BlackRock, HDFC Mutual Fund and IFC. Notably, IFC’s investment marks the World Bank Group’s return to India’s mainboard IPO market after five years, reflecting strong institutional confidence in Molbio’s diagnostics leadership.